Interferon-λ: Immune Functions at Barrier Surfaces and Beyond - Wikidata - wikimedia - TriplyDB

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

http://www.wikidata.org/entity/Q26801049

about

Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection Dengue virus infection induces interferon-lambda1 to facilitate cell migration Regulation of antiviral innate immune signaling by stress-induced RNA granules Expansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversity IFN-λ: A New Inducer of Local Immunity against Cancer and Infections Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections hrHPV E5 oncoprotein: immune evasion and related immunotherapies.The dynamic changes of interferon lambdas related genes and proteins in JAK/STAT pathway in both acute and chronic HIV-1 infected patients.Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections.Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.Impact of host genetic polymorphisms on vaccine induced antibody response A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.New fronts emerge in the influenza cytokine storm.Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo.Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.Cell Polarization and Epigenetic Status Shape the Heterogeneous Response to Type III Interferons in Intestinal Epithelial Cells.Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.Comparison of in vitro toxicological effects of biomass smoke from different sources of animal dung.Microbial pathogenesis and type III interferons.Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components.Targeting IFN-λ: therapeutic implications.Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.IFN-λ cancer immunotherapy: new kid on the block.Age-related alterations in immune responses to West Nile virus infection.Contribution of type III interferons to antiviral immunity: location, location, location.The Unresolved Role of Interferon-λ in Asthma Bronchiale.Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology.Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero.Downregulation of Interferon-β and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome.Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship.RNA-virus proteases counteracting host innate immunity.Interferon regulatory factor-1 (IRF-1) protects against chikungunya virus induced immunopathology by restricting infection in muscle cells.

P2860

Q23748220-7A6A135C-5EE2-438F-92F1-D78B6815FF63 Q26700107-E59ACFF0-845D-430A-BB67-54B769B61679 Q26770034-6DCBD1FD-B554-4123-AC37-1289E7C0152C Q27469006-F750B52C-1667-4B96-8F7C-CA7D16EF2B96 Q28072995-67F12B14-B696-4301-9F6C-2BBB188E1CD6 Q29451356-17B5B5AA-EAF3-4DE0-9503-E20CD81458E4 Q30145653-444DFD0E-A8A1-44CD-AE35-11F73195D321 Q33655568-98C47181-049D-428B-A9D3-71F72806A74F Q33730462-3AD1B9C1-161F-4BBF-B60C-DCA19A43AE96 Q33809104-E38DFE32-38A2-4D65-9BC0-E8A3B6783AD7 Q33854465-1B122A9D-C070-4500-9979-C1C38F1766BB Q35885281-1B318DBB-46DA-4D88-856A-0072D3AAEB19 Q36003428-4EC3C64F-68E1-4FD5-A22D-5987FB6DCCB0 Q36057888-3679E73D-C163-48CE-8C0A-1EEEEC3D39B5 Q37130716-F6E7067D-ADA0-482E-9E31-774602CB25BE Q37612580-42D60470-2CED-48FD-9C91-DD8576B0F746 Q38400762-F9757064-C3A1-4AF4-A1F0-776D36723F5F Q38623190-4EDB94E0-0537-4BB1-A249-2CD533474739 Q38668279-B3619EAA-4FB9-4E0B-9E9E-FD9337A0D601 Q38698679-FC203E02-2ADC-4563-87C3-12C4945AA48C Q38702032-636E5335-6EB9-4373-B606-0B0E006CAC1A Q38721800-1793E46A-28CB-4B44-9B64-ACE2DE3986F7 Q38733510-DF03FC6B-2286-47E4-9D48-EF5A01F44002 Q38750155-AC842C00-2AD7-403D-98AF-9F470319F537 Q38778598-D355BADF-79A3-40C9-8C53-919EFF320FE0 Q38806784-DFDCFB0D-1833-4850-9BF5-E977D620E45B Q38816811-A4CD1536-BDC9-490D-A5EA-AB2080FB763A Q38859455-21667EF6-99F9-450E-ACF5-7447E570E91A Q38887297-A1AACB00-A183-42E4-AFD0-55BC62BF2032 Q38950405-991E24BE-3142-4F17-9C78-15C56CAA6EC6 Q39176570-FC2ADD2C-88B8-40FB-8FA5-00CF022EADF4 Q39190363-CBBAAE71-D2B7-42D3-9979-EDC6570533BE Q39205799-01AF5874-404D-4590-B7C2-73FB1B3461B8 Q39327457-01B50519-E704-4520-B57F-9A15367FE091 Q39389626-11606B03-7DFF-4B67-A288-F99592D1A490 Q40037502-AEAE0D16-514E-4353-9EC4-ACCCE261852E Q40046124-2E81E76A-6ACD-4D5E-84D4-48BCC60487CC Q40054710-86869D2F-056E-4C22-9FD8-15E8E5172F0C Q40066626-A34D0C69-4DCE-486E-8DD3-62E503845455 Q40072937-83913531-A3FC-4399-9009-8329316A0E1A

P2860

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

http://www.wikidata.org/entity/Q26801049

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@ast

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@en

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@nl

type

label

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@ast

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@en

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@nl

prefLabel

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@ast

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@en

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@nl

P1433

Q26801049-CC8C3C0D-77EF-4C0A-8763-ACFC20C48EBB

P1476

Q26801049-B384B99F-FB70-4720-A047-2A1B47C09E41

P2860

Q26801049-015FF35B-36F2-4D4E-9B09-30C0B7AB226E

Q26801049-05C65267-9293-410B-A91D-2713DB57A00A

Q26801049-060B0729-A156-45F8-B779-A51D44D14A58

Q26801049-06FB9D00-8A5B-4689-BA41-634FFFB3EC78

Q26801049-071AE227-9783-45B5-8334-C043722291A6

Q26801049-08D2D076-9EE5-4964-BA46-9A87762BDEDB

Q26801049-09CF5A0E-9E91-4DE8-B6E7-F361B2D67EB9

Q26801049-0DD1AAFC-80E5-4B6F-9C04-528C7A2628E9

Q26801049-0DFEF32C-EF2D-49B7-98F8-D26197013812

Q26801049-0E37AF7C-BFD9-4776-92AD-0BBBE0421E00

P304

Q26801049-2AC3E590-5F4A-407A-AD56-EA2E64F7D96C

P31

Q26801049-475A1829-2EF6-4804-AA04-F71E62A0ACD3

P3181

Q26801049-46BCF0AF-1642-4998-9146-6CDD8FF18800

P356

Q26801049-32FC6C00-0C7C-4B3E-823B-170DCEC48F8F

P407

Q26801049-F866B0E2-7878-4761-85E5-9BAF335FEB35

P433

Q26801049-DFE305A3-44DC-4DD1-B069-D17CF892B852

P478

Q26801049-3C1FE676-211E-42BB-8817-8E497C81178D

P50

Q26801049-0C557DA1-AC8A-4BA4-8D53-9432C0546160

Q26801049-8BD61F00-2109-4963-B75B-4595B3449804

Q26801049-AAFF47CB-A9C8-4E0B-90B3-31739716CC98

P577

Q26801049-6DAB1ADF-7E73-475C-AEFD-FBD53F91903F

P698

Q26801049-895D9AAD-FDCB-41DF-B044-7263EE043E86

P932

Q26801049-F9CEAFF3-A112-47DD-A273-619E28A43A06

P3181

P356

J.IMMUNI.2015.07.001

P1433

P1476

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

@en

P2860

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

IL-28, IL-29 and their class II cytokine receptor IL-28R

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?

Subversion of cytokine networks by virally encoded decoy receptors

P304

15-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

379301

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.IMMUNI.2015.07.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Helen M. Lazear

P577

2015-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26200010

http://www.w3.org/2001/XMLSchema#string

P932

4527169

http://www.w3.org/2001/XMLSchema#string